Dow Gives Back 395 Points to 51,837, S&P 500 Dips to 7,798, Nasdaq Holds 27,200 as MU Drops to $945

The Dow Jones Industrial Average opened Tuesday, October 13, 2026, like a market that had found its catalyst. Dow futures traded at 52,580, up 470 points or 0.90%, ten minutes before the bell, and the cash index printed 52,245.14 shortly after the open, a gain of 394.59 points or 0.76% on Monday’s close of 51,850.55. By 10:30 a.m. ET the index sat at 51,837.83, down 12.72 points or 0.02%. Roughly 407 points of upside, gone in under an hour, on a morning when the earnings news was mostly good.

The S&P 500 never had the lift. It opened down 0.07% and was trading at 7,798.11 by mid-morning, off 9.13 points or 0.12%, leaving it 46.56 points, or 0.6%, below its all-time high of 7,844.67 set earlier this month. The Nasdaq Composite opened down 0.31% and was quoted at 27,200.61, a 0.17% decline that is smaller than the 0.36% hole it opened in. The Russell 2000 sat at 2,782.21, down 12.27 points or 0.44%, extending Monday’s 0.45% drop.

That combination is the session’s real signal. Banks and health care delivered a cluster of beats and raised forecasts before 8 a.m., and the price-weighted Dow pulled 400 points of value out of them on the opening bell. Then the bid faded. The memory-chip liquidation that started in Seoul overnight kept compounding, and the Nasdaq actually stabilized while the Dow surrendered its gains, which tells you buyers were rotating out of the earnings winners rather than into them.

Context matters for a tape this split. Monday closed with the Dow up 0.38% at 51,850.55, the S&P 500 down 0.06% at 7,807.24, the Nasdaq down 0.44% at 27,245.90 and the Nasdaq 100 down 0.71% at 30,664.70. Technology was the worst of 11 sectors at minus 1.22%, while real estate led at plus 2.62%, energy added 1.43% and consumer staples rose 1.17%. Year to date through Monday, the S&P 500 was up 13.83%, the Nasdaq Composite up 17.26%, the Dow up 7.17% and the Russell 2000 up 11.41%.

Volatility stayed contained. The VIX traded at 15.31, up 0.66%, after closing Monday at 15.21. That is not a fear reading; it is a market repricing a single industry, memory, while the index-level cushion holds. The 10-year Treasury yield eased to 5.22% from 5.24%, which would normally help growth stocks, and it did not stop the semiconductor complex from rolling over for a second straight session.

The thesis for the day is narrow and specific: an earnings season that consensus expects to deliver 30.6% profit growth for the S&P 500 in the July-September quarter opened with solid numbers, and the tape treated those numbers as secondary to a supply-side threat in the most crowded AI trade on the board. Until memory stabilizes, the beats get sold.

Seoul Breaks First: KOSPI Sinks 5.5% as CXMT’s 4F² DRAM Design Hits Samsung and SK Hynix

The damage started overnight in Asia. South Korea’s KOSPI fell 5.5% to 6% depending on the print, with Samsung Electronics down 7.39% and SK Hynix down roughly 8% in Seoul, extending both stocks’ losing streaks to five sessions. Those two companies account for more than half of the South Korean market’s total capitalization, so a memory-specific shock becomes a national index event almost mechanically. Tokyo Electron, the chip equipment maker, fell 7.2% in Japan.

The trigger is a design announcement out of China. ChangXin Memory Technologies, the Shanghai-listed DRAM maker known as CXMT, said over the weekend through its president Cao Kanyu that it has made progress on a 4F² DRAM cell structure, an architecture engineered to pack more storage into less silicon area. CXMT plans to introduce a server memory product built on that design by the end of 2026. CXMT’s own shares fell 2.79% in Shanghai, which says the market sees this as a threat to incumbents more than a windfall for the challenger.

Why this hits so hard: Samsung, SK Hynix and Micron have been printing enormous profits in 2026 on the back of supply discipline as much as AI demand. The high-bandwidth memory and server DRAM shortage has been the profit engine. A credible Chinese entrant in server-grade DRAM, at a denser cell structure, attacks the pricing power directly, not just the volume. The market does not need CXMT to ship at scale to reprice the incumbents. It only needs the probability of future oversupply to rise.

Monday already showed the shape of the trade. The Philadelphia Semiconductor Index fell 2.7% on Monday, a DRAM-focused index dropped 4.32% and the broad semiconductor ETF lost 2.05%. AMD fell 2.28% and Broadcom 1.88% on the day. Optical and networking hardware got smoked alongside memory: Cerebras Systems dropped 10.69% to $146.62, Semtech fell 10.15% to $168.28, Ciena lost 9.95% to $405.01 and Lumentum gave back 9.78% to $995.41. Five hardware names down near 10% in a single session is a positioning unwind, not a news reaction confined to one company.

Tuesday made it worse because the Asian session handed U.S. traders a fresh 5% index drop to price at the open. SK Hynix’s U.S.-listed shares, SKHY, traded at $155.11, down $7.12 or 4.39%, with 9.43 million shares changing hands by mid-morning and a market value of $1.103 trillion. The 52-week range of $124.80 to $199.87 puts the stock 22% below its high.

There is a second layer of risk embedded in the morning’s premarket notes: a potential labor strike in Taiwan was cited alongside the CXMT news as weighing on Micron. Supply disruption and supply competition pull in opposite directions on price, but both raise uncertainty, and uncertainty is what a stock trading at extreme year-over-year gains cannot absorb cleanly.

Micron Slides to $945.03, Storage Gets Smoked: Western Digital Down 7.71%, Seagate Down 7.28%

Micron Technology was one of the heaviest single weights on the S&P 500 Tuesday morning. The stock traded at $945.03 by 10:30 a.m. ET, down $44.01 or 4.45%, after trading as low as 5.8% lower in the first minutes of the session. At a $1.069 trillion market capitalization, the drop erased $50 billion in value before 11 a.m. Volume hit 10.02 million shares in the first hour against a three-month daily average of 32.3 million, a pace that projects well above normal turnover.

The scale of the move needs the right frame. Micron is up 428.73% over the past 52 weeks, with a range from $186.25 to $1,255.00. At $945.03, the stock is 25% off its peak. A two-day slide of 4% on Monday and 4.45% on Tuesday is not a collapse for a name that ran that far; it is the market pulling forward the risk that 2027 DRAM pricing will not look like 2026 DRAM pricing. The stock carried a trailing P/E of 13.84, which looks cheap only if peak-cycle earnings hold.

Premarket, Micron was down 2.8% at 5:50 a.m. ET, 3% by 7 a.m., and 4.8% by 8:43 a.m. Each print was lower than the last, which tells you sellers were not waiting for the open to see if Seoul’s move would stick.

Storage got hit harder than memory. Western Digital tumbled 7.71% in premarket trading after a price-target cut to $470 from $525. Seagate Technology sank 7.28% on the broader storage selloff, with reports of a multibillion-dollar acquisition bidding war and intensifying global competition in the mix. SanDisk fell between 6% and 7% in premarket, after dropping 6% on Monday. Storage and memory trade as one cycle in this market, and the CXMT news hit the whole capacity-constrained chain at once.

AMD fell 3.3% after the open and Marvell Technology dropped 3% in premarket. Nvidia shed 0.8% before the bell but traded at $225.68 by 10:30 a.m., down just $0.64 or 0.28%, on 20.37 million shares. Nvidia’s $5.449 trillion market value and its position as a buyer of memory rather than a seller make it a different trade: a cheaper DRAM future is a lower input cost for GPU systems, and the tape seems to be recognizing it.

Intel traded at $100.27, down 1.07%, with a $530 billion market capitalization. The stock is up 184.45% over 52 weeks but sits well below its $142.35 high.

The structure here is the cleanest part of the day. Memory and storage are getting liquidated. GPU and CPU leaders are barely moving. That is a sector-specific repricing of supply risk, not a broad AI capitulation, and it is why the S&P 500 is only down 0.12% while individual chip names are down 4% to 8%.

Broadcom CEO’s “Casino” Comment Lands on an AI Trade Already Losing Altitude

The memory selloff did not happen in a vacuum. On Monday, at an event in Singapore, Broadcom CEO Hock Tan said many AI investors “have no clue what they are investing in,” and compared the speculative behavior to gambling in a casino. Coming from the chief executive of one of the largest custom AI accelerator suppliers on the planet, the comment hit sentiment harder than any sell-side downgrade could. Broadcom fell 1.88% on Monday and dipped another 1% in premarket Tuesday, alongside Nvidia and Qualcomm.

That rhetoric matters because of where expectations sit going into the real AI earnings wave. After two straight quarters of large upside surprises that pushed the indices to records, beats have become the baseline. The question now being priced is whether AI capital spending can grow again in 2027 and whether it gets monetized. A CEO calling the speculative fringe a casino is a direct challenge to the multiple investors are paying for that durability.

The AI infrastructure lane felt it across the board Tuesday morning. CoreWeave traded at $77.88, down $2.38 or 2.97%, with 10.14 million shares by mid-morning and a market capitalization of $42.95 billion; the stock is down 40.13% over 52 weeks and sits $17 above its 52-week low of $60.55. Applied Digital fell 5.61% to $21.94. The bitcoin-miners-turned-AI-hosting names, which have been trading as levered data-center plays, were under heavy pressure: Cipher Digital collapsed 15.81% to $10.94 on 34.81 million shares, trading below its prior 52-week low of $11.72. IREN fell 3.66% to $33.53 and TeraWulf dropped 3.63% to $12.89, even with bitcoin up 1.35% at $83,606.

SpaceX, now trading publicly under SPCX after its June 12 debut at $135, fell 3.86% to $157.12 on 18.37 million shares. The stock peaked at $225.64 on June 16 and is now 30% below that level, with a $2.071 trillion market capitalization. A Falcon 9 carrying NASA’s CRS-35 cargo mission launched at 6:33 a.m. ET from Cape Canaveral, the company’s 35th resupply mission to the International Space Station, and it did not move the stock.

AST SpaceMobile dropped 9.42% to $46.62, below its prior 52-week low of $47.57, extending a slide that started with last Thursday’s telecom wipeout.

On the other side of the AI ledger, the morning brought a fresh macro warning. The IMF flagged an AI slowdown and spiking bond yields as looming risks to global markets. With the 10-year yield at 5.22%, the cost of capital for long-duration AI projects is the highest it has been in more than two decades, and a CEO publicly questioning investor discipline lands harder in that rate environment than it would have at 4%.

JPMorgan Prints $15.3 Billion Profit but Misses at $5.57 a Share as Dimon Flags Forces “Shifting Under the Surface”

JPMorgan Chase opened bank earnings season with the only clear miss among the majors. The largest U.S. bank reported third-quarter net income of $15.3 billion, or $5.57 per share, up 6% from a year earlier. The consensus sat at $5.90, so the print came in 33 cents short. Net revenue rose 8% to $50.2 billion from $46.4 billion in the third quarter of 2025.

The miss has an asterisk. JPMorgan booked $658 million in pretax losses on investment securities, and excluding that item the bank earned $5.75 a share. That still leaves a 15-cent gap to consensus, so the adjustment narrows the miss without erasing it. Securities losses in a quarter where the Fed hiked in September and the 10-year pushed above 5.2% are the most predictable line item in the release. Banks holding fixed-rate bonds bought at lower yields are carrying unrealized losses, and JPMorgan chose to crystallize some of them.

Investment banking fees came in at $3 billion, up 14% from a year earlier but down 8% from the second quarter. CFO Jeremy Barnum told reporters that dealmaking slowed in the back half of September as market volatility widened the gap between buyer and seller expectations. His framing: he would “lean more on the side of delayed rather than canceled.” He also cautioned that it remains unclear whether activity will accelerate in the fourth quarter.

CEO Jamie Dimon’s statement carried the sharpest line of the morning. He credited strong business investment and continued consumer spending for the U.S. economy’s strength, then listed the risks: large fiscal deficits, sticky inflation, elevated asset prices, rising interest rates and geopolitical conditions, which he said “continue to shift under the surface.” He added that these forces may be manageable but that the bank remains prepared for a wide range of outcomes.

The stock reaction tells you how low the bar had become. JPMorgan shares rose 1.02% in premarket trading despite the miss. Options had priced an earnings move between 3.4% and 5.2% depending on the snapshot, so a 1% gain on a miss is a market that came in braced for worse. Bank stocks had a rough three months coming into the print: the KBW Nasdaq Bank Index fell 8.4% over that stretch while the S&P 500 gained more than 3%. Inflation and the bond selloff hit revenue expectations and pressured bond portfolios, and many banks are sitting on unrealized losses.

JPMorgan entered the week at $332.99 as of Friday’s close and carries a market value of $970 billion. The setup was simple: positioning was light, sentiment was poor, and a modest miss with a clean explanation did not trigger the selling the options market had priced.

Goldman Sachs Earns $17.01 as Equities Revenue Rips 72% to $6.44 Billion

Goldman Sachs delivered the strongest bank print of the morning. Third-quarter profit came in at $5.29 billion, or $17.01 per share, against $4.10 billion, or $12.25 per share, a year earlier. That is a 29% jump in net income and a 39% increase in earnings per share, well above consensus.

The engine was equities trading. Goldman’s equities business posted revenue of $6.44 billion, up 72% from a year earlier. The drivers were the conditions the rest of the market hated: the Fed’s September rate hike, the spike in fuel costs tied to the Middle East conflict, and the chip-stock selloff all forced institutional investors to reshuffle portfolios aggressively. That reshuffling runs through prime brokerage and trading desks, and Goldman’s equity financing business, lending to clients so they can trade stocks, captured a large share of the flow.

Fixed income, currencies and commodities was the soft spot. FICC revenue came in at $3.47 billion, down 1% from a year ago. Goldman’s FICC line has been volatile all year: it fell 10% in the first quarter when the rates business was hit by volatility from the Iran war, then surged 32% in the second quarter before slipping in the third. Investment banking was a clear beat relative to consensus, a sign that the deal pipeline is intact even after JPMorgan described a late-September slowdown.

CEO David Solomon described a “complicated operating environment” and said the firm remains well positioned to deliver for clients despite current complexity and uncertainty. That is a measured statement for a quarter in which one business line grew 72%.

The stock reaction followed the Dow’s arc almost exactly. Goldman rose 3.47% in early premarket, extended to a 4.20% gain later in the premarket session and was cited as up 3.5% at 8:43 a.m. ET. By 9:35 a.m. ET the gain had shrunk to 1.4%. Goldman entered the week at $895.32, and with the Dow being price-weighted, a stock at that price level is one of the index’s heaviest components. A 4% premarket move in Goldman alone translates to more than 200 Dow points. When that gain got cut to 1.4% after the open, a large part of the Dow’s opening rally went with it.

That is the cleanest single explanation for the Dow’s 407-point round trip. The index was not lifted by broad buying. It was lifted by two heavyweights, Goldman and UnitedHealth, reacting to beats, and when profit-taking hit both of them in the first 15 minutes, the Dow went back to unchanged.

Goldman’s market value sits at $306 billion. With equities volatility unlikely to fade while chips are swinging 5% a day and oil is whipsawing on Houthi headlines, the trading revenue tailwind looks set to carry into the fourth quarter.

Citigroup Earns $2.85 and Wells Fargo $1.87 as Credit Provisions Start Climbing

Citigroup reported third-quarter net income of $5.2 billion, or $2.85 per diluted share, on revenue of $23.8 billion, according to its filing with the SEC. A year earlier it earned $3.8 billion, or $1.86 a share, on revenue of $22.1 billion, a quarter that included a $726 million goodwill impairment tied to the Banamex stake sale. Stripping that item, prior-year EPS was $2.24, so the clean comparison is 27% growth; reported EPS jumped 53%. Revenue grew 8%. Consensus had been $2.67 on $23.29 billion, so Citi cleared both lines and extended a streak of eight consecutive EPS beats.

Capital return stayed heavy. Citi returned $4.1 billion through buybacks and dividends for an 85% payout ratio, held its CET1 ratio at 12.8% and reported book value per share of $115.61 with tangible book at $101.59. Banking revenue grew 6% with particular strength in equity capital markets, where Citi participated in the quarter’s six largest transactions. The stock came into the print battered: shares fell 7.5% during the third quarter against a 2.9% decline for the industry.

Wells Fargo reported net income of $5.95 billion, or $1.87 per diluted share, up 13% from $1.66 a year ago, per its earnings release. Total revenue rose 2% to $21.87 billion. Net interest income grew 5% to $12.52 billion while noninterest income slipped 1% to $9.35 billion. Average loans crossed $1 trillion at $1,033.4 billion, up 11%, and average deposits rose 11% to $1,482.9 billion. Return on tangible common equity hit 16.3%.

The line that matters for the macro read is credit. Wells Fargo’s provision for credit losses jumped 51% to $1.029 billion from $681 million. Net charge-offs rose to $983 million, 0.38% of average loans. Commercial net charge-offs as a share of loans climbed to 0.18% from 0.10% in the second quarter, driven by commercial real estate and commercial and industrial loans, while the consumer charge-off rate fell to 0.70%. Citi and Wells both increased total provisions for potential loan losses despite credit conditions that remain benign.

Net interest margin compressed to 2.43% from 2.61% a year ago, an 18-basis-point squeeze. CET1 fell to 10.0% from 11.0%, a 100-basis-point drawdown as Wells deploys capital after the asset cap came off; the bank repurchased 28.6 million shares for $2.5 billion in the quarter. Headcount is down 8% from a year ago.

CEO Charlie Scharf said the bank’s data shows consumer and business customers are doing well, with spending up, delinquencies low and balances growing. He named higher interest rates, higher oil prices and persistent inflation as the risks, and said AI infrastructure investment, high employment and steady wage growth continue to outweigh them.

Bank of America, at $53.94 and down 1.16% this morning, and Morgan Stanley report Wednesday.

UnitedHealth Lifts 2026 Floor to $20.50 on an 88.4% Medical Care Ratio and Carries the Dow’s Open

UnitedHealth Group was the single biggest contributor to the Dow’s early rip. The largest U.S. health insurer reported third-quarter revenue of $112.7 billion, earnings from operations of $6.6 billion and adjusted earnings of $4.69 per share, with GAAP EPS at $4.56, according to its SEC filing. Cash flow from operations came in at $5.1 billion, 1.2 times net income.

The guidance raise is the headline. UnitedHealth now expects full-year 2026 adjusted earnings of at least $20.50 per share and GAAP earnings of at least $19.50. After the second quarter, the company had guided to $19.50 to $20.00 adjusted, which itself was a large lift from the prior floor above $17.75. The new floor sits 50 cents above the old top of the range, a 2.5% raise on the high end.

The number investors watch most is the medical care ratio, the share of premium revenue paid out in claims. It came in at 88.4% for the third quarter. That compares with 86.7% in the second quarter, which benefited from $860 million in favorable prior-period reserve development, and with 89.9% in the third quarter of 2025 when medical cost trends were running at historic highs. The company credited medical cost management, pricing discipline, benefit design changes and care delivery enhancements. The operating cost ratio fell to 12.8% from 13.5% a year earlier, a 70-basis-point improvement that reflects the push to modernize operations and strip administrative cost.

CEO Stephen Hemsley framed the quarter around discipline and execution as the company works toward a simpler experience for patients and clinicians. Optum’s clinical care unit reported improved margins, which matters because Optum Health’s value-based care margins had been under 1% a year ago.

The stock reaction mirrored Goldman’s. UnitedHealth rose 4.30% in early premarket, extended to 5.28% and was up 4.4% at 8:43 a.m. ET. It opened with a 5% gain that led the Dow’s advance, then was cited up 2.6% at 9:35 a.m. ET and 3.17% shortly after, settling near 3% by mid-morning. Health care peers moved with it: in the managed care group, the guidance raise is read as confirmation that 2026 repricing actions are working across the industry.

The context makes the beat more significant. UnitedHealth collapsed in 2025, withdrew guidance, reinstated it and then missed, and the stock fell roughly 20% in a single session in January of this year on an earnings disappointment. It rallied 21% after the July guidance raise. Each step in this recovery has been about one thing: proving that the medical care ratio is under control. An 88.4% print that lands between the strong second quarter and the ugly 2025 levels, plus a higher floor, does that.

In a price-weighted Dow, a 5% opening gain in UnitedHealth combined with Goldman’s 4% premarket move accounted for most of the index’s 395-point opening advance. When both gains were cut roughly in half, the Dow’s rally evaporated.

Johnson & Johnson Tops $25.4 Billion in Sales but a Talc Charge Cuts GAAP EPS to $0.09

Johnson & Johnson posted third-quarter sales of $25.4 billion, up 5.9% on a reported basis with operational growth of 6.0% and adjusted operational growth of 6.1%, according to its earnings exhibit filed with the SEC. Revenue consensus had been $25.29 billion, so the top line came in ahead.

The GAAP earnings figure looks alarming at first glance: $0.09 per share. That number reflects a one-time special charge for the proposed talc litigation resolution, plus the costs of acquiring Firefly Bio and the strategic collaboration with Sail Biomedicines. Adjusted EPS came in at $2.59, and that figure also absorbs the impact of the M&A deals. The talc charge is the company’s attempt to close out one of the longest-running liability overhangs in large-cap health care.

J&J raised full-year guidance on operational performance. The company now expects 2026 reported sales of $101.2 billion at the midpoint, 7.4% growth, up from the $101.1 billion midpoint set in July. That puts it on track for its first year above $100 billion in annual revenue in its 140-year history. Adjusted EPS guidance rose by $0.06 to $11.10 at the midpoint, 2.9% growth, a lower figure than the pre-deal guidance because it now includes the dilution from the acquisitions.

Pipeline news was dense. J&J highlighted market authorization for OTTAVA, described as the world’s first table-integrated soft tissue robotic surgical system, approval of IMAAVY in warm autoimmune hemolytic anemia, and priority review for RYBREVANT FASPRO in advanced head and neck cancer. Pharmaceutical sales remained strong.

The stock moved lower anyway. The culprit was a weaker-than-expected result in the medical device business, MedTech, which has been the soft segment all year. Cardiovascular is now MedTech’s largest and fastest-growing unit through electrophysiology, Shockwave and Abiomed, and the market wanted acceleration there to offset Stelara biosimilar erosion on the pharma side. It did not get enough of it.

The pattern repeats J&J’s July print, when the company beat and raised and the stock fell 2.7% on the report session before recovering 7.7% over the following weeks. Health care investors have learned to treat J&J’s guidance raises as expected and to trade the segment mix instead.

In the broader health care tape, the contrast with UnitedHealth is sharp. Managed care is being rewarded for proving cost control. Diversified pharma and medtech is being held to a segment-by-segment standard where any shortfall in devices outweighs a raise in total guidance. Health care was a 0.69% gainer on Monday, the fourth-best sector, and Tuesday’s earnings split the group down the middle.

Megacaps Refuse to Follow the Chips: Apple Breaks to $346.17, Meta Gains 3.25%

The most important reason the Nasdaq trimmed its loss from 0.36% to 0.17% is that the largest non-semiconductor names did not join the selloff. They went the other way.

Apple traded at $346.17 by 10:30 a.m. ET, up $5.20 or 1.53%, on 11.78 million shares. That price sits above the stock’s prior 52-week high of $345.34, a fresh breakout. Apple’s market value reached $5.052 trillion, and the stock is up 37.62% over the past 52 weeks. For a company that consumes memory rather than sells it, a credible new DRAM supplier in China is, on the margin, a cost tailwind for device bill of materials.

Meta Platforms rose $24.18, or 3.25%, to $767.14 on 8.33 million shares, pushing toward its 52-week high of $779.82. Meta’s market value is $1.954 trillion. As one of the heaviest buyers of AI compute and memory, Meta benefits from the same logic: a supply-side threat to memory pricing is a capex-relief story for hyperscalers.

Nvidia, as noted, held near flat at $225.68, down 0.28%, with its $5.449 trillion valuation intact. The stock remains 7% below its 52-week high of $243.37.

That is the internal rotation that explains the morning. Money came out of memory, storage and AI-hosting names and went into the platforms that pay those suppliers. It is a coherent trade: if CXMT’s 4F² architecture compresses DRAM margins in 2027, the profit pool shifts from Micron, SK Hynix and Samsung toward Apple, Meta and the cloud builders. The Nasdaq’s partial recovery is the market executing that shift in real time.

Other heavy-volume names showed scattered risk appetite in consumer and media. AT&T rose 1.78% to $22.89, recovering some ground after last Thursday’s telecom collapse sent the stock down 9.81%. Snap gained 3.83% to $6.78 on 10.27 million shares. AMC Entertainment jumped 5.33% to $3.16. Fermi Inc. was the volume leader at 39.23 million shares, ripping 21.23% to $3.94, though the stock remains down 89% over 52 weeks.

Paramount Skydance traded flat at $9.77 on 31.66 million shares, heavy volume with no direction. Nokia slipped 0.96% to $9.81.

The Hartford Insurance Group rose 4.95% in premarket trading, another sign that financials outside the big four banks found buyers in the early going.

The breadth read is mixed rather than weak. The Russell 2000 is down 0.44%, so small caps are not participating. But the megacap tier is absorbing the rotation out of semis without letting the Nasdaq unravel. That keeps the S&P 500 within 0.6% of its record even on a day when its most volatile sector is down sharply.

10-Year at 5.22%, a September Fed Hike Behind Us and CPI Ahead

The rate backdrop is what makes this earnings season different from any in the past two decades. The 10-year Treasury yield traded at 5.22% Tuesday morning, down from 5.24% at Monday’s close. Last week yields hit their highest levels since 2002, and the Federal Reserve raised rates in September, a move that drove a large part of the volatility that fattened Goldman’s equities revenue.

The bond market was closed Monday for the Columbus Day holiday, so Tuesday is the first full session of Treasury trading this week. The 2-basis-point dip is modest and came with oil sliding in the premarket. It did not translate into a rally in rate-sensitive tech, which says equity investors are focused on sector supply risk rather than discount rates today.

Rates are biting the real economy in visible ways. Mortgage rates are approaching 7.5%, and the Treasury secretary has been pressing a bond-market fix as housing affordability deteriorates. The day’s economic calendar features September existing home sales, expected to fall 0.8% month over month after a 2% decline in August. NFIB small business optimism for September was expected at 98, against 98.7 prior. The weekly ADP employment change for the week ended September 26 showed a prior reading of plus 23,750.

Fed speakers are active. Governor Christopher Waller, Richmond Fed President Tom Barkin and Boston Fed President Susan Collins are scheduled to deliver remarks on the economy Tuesday. With the October 27-28 FOMC meeting two weeks out, any signal on whether the September hike was a one-off or the first of several will move yields more than the housing data.

The main event is September CPI, due later this week. A hotter reading could bring back expectations of an October rate hike, which would put both the equity rally and bank earnings under a tougher test. That risk explains part of Tuesday’s caution: investors are not eager to chase cyclical winners like banks into an inflation print that could push the 10-year back toward recent highs.

The bank releases themselves echo the rate story. JPMorgan’s $658 million in securities losses, Wells Fargo’s 18-basis-point NIM compression to 2.43% and the 100-basis-point drawdown in its CET1 ratio are all the balance-sheet footprint of higher-for-longer. Dimon listed rising interest rates as one of the forces shifting under the surface, and Scharf named higher interest rates first among his risks.

Gold traded at $4,193.60, up 0.07%, after reaching $4,210.40 in early trading. Silver futures were up 0.18% at $60.62. The U.S. Dollar Index closed Monday at 102.55. Gold above $4,190 with 10-year yields above 5.2% is an unusual pairing, and it tells you the bid in precious metals is about geopolitical and fiscal risk, not real rates.

Oil Round Trip: WTI Drops to $91.78 on Russian Diesel Waiver, Then Claws Back to $93.68

Crude added a second layer of volatility to the morning. West Texas Intermediate fell 2.09% to $91.78 a barrel in early trading and Brent dropped 2.09% to $104.40, after Brent had topped $105 in the prior session. By 10:30 a.m. ET, the November WTI contract was back at $93.68, down just 0.06%. A 2% slide wiped out and reversed inside the same morning, mirroring the Dow’s round trip.

The early selling came from Washington. The Trump administration temporarily eased restrictions on Russian diesel supplies, a measure that would allow Russia to supply diesel to U.S. and global markets for six months. President Trump defended the decision on Truth Social, arguing the European Union had spent billions on Russian energy imports, despite bipartisan criticism from lawmakers who warned it undermines sanctions tied to the war in Ukraine. Chevron’s CEO called a related decision on diesel and fuel exports unwise. Hopes of de-escalation between Russia and Ukraine in their strikes on each other’s energy infrastructure have moderated.

The recovery came from the Gulf. The Saudi-Houthi conflict is escalating, and Trump said he is considering joining the Saudi-led campaign against the Houthis in Yemen. A Houthi official warned of a swift and painful response if the U.S. enters. At least 20 people, including a U.S. national, have been killed in a week of Houthi attacks on Saudi Arabia, and Saudi Arabia extended the suspension of operations at Riyadh’s King Khalid International Airport until Saturday. Qatar’s emir called for greater efforts to secure shipping through the Strait of Hormuz and protect energy facilities.

Iran is reportedly fortifying nuclear sites ahead of possible U.S. strikes after the November 3 midterm elections, and Trump said last Thursday that U.S. forces would not attack Iran before those elections. That timeline puts a geopolitical calendar on oil that runs right through November.

The consumer is already feeling it. Gasoline prices have tied 2022’s record for the most days above $4 a gallon in a single year. Crude-sensitive stocks in other markets are being hit with Brent above $104, and with Dimon and Scharf both naming oil as a macro risk, energy prices are now a direct input into the credit outlook.

Energy equities are the year’s best trade by a wide margin: the sector ETF is up 44.60% year to date through Monday, after a 1.43% gain on Monday as WTI rose 1.59% to $93.31. Tanker operators have been the hottest corner. DHT Holdings rose 6.41% to $26.22 on Monday, Frontline gained 5.51% to $59.19 and Okeanis Eco Tankers added 5.93% to $98.63, with each stock up between 134% and 242% over 52 weeks.

For equities, the oil whipsaw adds one more reason to stay away from rate-sensitive cyclicals until CPI prints.

Breadth, Small Caps and the Sector Map: Russell 2000 at 2,782 as Leadership Narrows

Strip out the index headline numbers and the participation picture is narrow. The Russell 2000 at 2,782.21, down 0.44%, is extending a two-day slide from Monday’s close of 2,794.48 and sits well below the Dow’s flat line and the Nasdaq’s partial recovery. Russell futures had traded up 0.22% at 2,818.50 before the open, so small caps opened lower than the premarket implied and never found buyers.

That gap is important. Small caps are the most rate-sensitive and the most dependent on domestic credit, and with the 10-year at 5.22%, a September Fed hike behind and CPI ahead, there is no reason to own them on a day when the macro tone is defensive. The Russell is up 11.41% for the year through Monday, lagging the Nasdaq’s 17.26% and the S&P’s 13.83%.

The sector map coming into Tuesday showed rotation into defense. Monday’s leaders were real estate at plus 2.62%, energy at plus 1.43%, consumer staples at plus 1.17%, health care at plus 0.69%, financials at plus 0.58% and utilities at plus 0.53%. The laggards were technology at minus 1.22%, communication services at minus 0.55% and consumer discretionary at minus 0.51%. Year-to-date returns diverge enormously: energy at plus 44.60% and technology at plus 36.08% at the top, financials at plus 0.22%, utilities at minus 3.59%, communication services at minus 4.66% and consumer discretionary at minus 5.14% at the bottom.

Tuesday’s early action extended part of that pattern and broke another. Technology remained the drag through semiconductors. Financials should have led on the bank beats but the gains faded with Goldman’s, and Bank of America slipping 1.16% to $53.94 ahead of its own print shows the sector bid was selective. Health care split, with UnitedHealth up near 3% and J&J lower. Communication services flipped positive on Meta.

Financials’ 0.22% year-to-date gain is the most telling number on the board. Bank earnings are growing at double-digit rates, Wells Fargo posted 13% EPS growth, Citi 27% excluding a one-time item, Goldman 39%, and the sector is flat for the year. The market is pricing the balance-sheet risk from 5%-plus yields, the rising provisions and the deal slowdown that JPMorgan described, and discounting the earnings.

Overseas markets helped the morning tone. In Europe, the DAX added 0.76% to 25,277.68 on Monday and the Euro Stoxx 50 rose 0.45% to 6,201.22, with European banks leading a 1.21% recovery after an 8% two-session slide. Britain’s FTSE 100 rose 0.7% at midday Tuesday, France’s CAC 40 gained 0.1% and Germany’s DAX climbed 0.3%.

The net picture: S&P 500 holding near records on megacap support, Dow flat after a heavyweight-driven pop, Nasdaq bleeding modestly from semis, small caps lagging. That is narrow leadership, not broad participation.

Verdict: Mixed Session With a Bearish Tilt Under the Surface

Tuesday’s session, as it stood at mid-morning, earns a mixed verdict with a bearish tilt underneath. The S&P 500 at 7,798.11, down 0.12%, is holding within 0.6% of its record, and the 15.31 VIX says there is no panic. On that surface reading, the market absorbed a 5.5% collapse in South Korea and a second straight day of semiconductor liquidation without breaking. That is resilience.

The internals tell a harder story. Earnings did their job: Goldman earned $17.01 a share with a 72% surge in equities revenue, Citigroup cleared consensus at $2.85, Wells Fargo grew EPS 13% to $1.87, and UnitedHealth raised its 2026 floor to $20.50 on an 88.4% medical care ratio. Those are strong prints. The Dow’s reaction was a 395-point rip at the open followed by a full round trip to 51,837.83 within an hour, as Goldman’s premarket gain of 4.20% shrank to 1.4% and UnitedHealth’s 5.28% gain was cut to 3%. When the market sells good news that fast, it is signaling that positioning and macro risk outweigh fundamental beats.

The dominant force is the memory trade. Micron at $945.03, down 4.45% and 25% off its high, Western Digital down 7.71%, Seagate down 7.28% and SK Hynix down 4.39% show a crowded AI supply chain being repriced on a single competitive threat: CXMT’s 4F² DRAM architecture and its end-2026 server memory target. Hock Tan’s casino comment added a credibility shock from inside the industry. The rotation into Apple at a fresh high of $346.17 and Meta up 3.25% to $767.14 is the market’s rational response, moving profits from suppliers to buyers, and it is the only reason the Nasdaq is down just 0.17%.

Behind all of it sits a 5.22% 10-year yield, a Fed that hiked in September, oil whipsawing between $91.78 and $93.68 on Russian diesel and Houthi headlines, and a CPI print later this week that could put an October hike back on the table. JPMorgan’s $658 million in securities losses, Wells Fargo’s 51% jump in provisions and its 2.43% net interest margin are the bank-level evidence that rates are biting.

The Russell 2000 at 2,782.21, down 0.44%, confirms that breadth is thin. Leadership is concentrated in a handful of megacaps and the two Dow heavyweights that reported beats, and even those faded.

The key levels to watch into the close: whether the S&P 500 holds above 7,798 and the 7,765 low from last Wednesday’s session, whether Micron finds support above $900, and whether the Dow can reclaim 52,000. Bank of America and Morgan Stanley report Wednesday, with CPI to follow. Until memory stabilizes and inflation data clears, beats will keep getting sold into strength.

That's TradingNEWS